Cosmos Health (COSM) grants 20,000 shares of stock to director

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Cosmos Health Inc. director Suhel Bhutawala received an award of 20,000 shares of common stock valued at $0.283 per share on May 19, 2026 under the company’s 2024 & 2025 Omnibus Incentive Plan. These shares came from restricted stock units that vested immediately and were converted into common stock in transactions exempt under Rule 16b-3. Following the award and RSU conversion, Bhutawala directly holds 65,000 shares of Cosmos Health common stock.

Insider Trade Summary

20,000 shares exercised/converted

Mixed 2 txns

Insider Bhutawala Suhel

Role null

Type	Security	Shares	Price	Value
Conversion	Restricted Stock Unit	20,000	$0.00	--
Grant/Award	Common Stock, par value $.001	20,000	$0.283	$6K

Holdings After Transaction: Restricted Stock Unit — 0 shares (Direct, null); Common Stock, par value $.001 — 65,000 shares (Direct, null)

Footnotes (1)

Reflects the award of 20,000 shares of Common Stock granted on May 19, 2026, pursuant to the Issuer's 2024 & 2025 Omnibus Incentive Plan, in a transaction exempt under Rule 16b-3. The RSUs were granted on May 19, 2026, under the Issuer's 2024 & 2025 Omnibus Incentive Plan and vested on the date of the grant, in a transaction exempt under Rule 16b-3.

Key Figures

Equity grant: 20,000 shares Grant value per share: $0.283/share Shares held after transaction: 65,000 shares +2 more

5 metrics

Equity grant 20,000 shares Common stock award to director on May 19, 2026

Grant value per share $0.283/share Reported transaction price for 20,000-share award

Shares held after transaction 65,000 shares Director’s direct holdings following the award

RSUs converted 20,000 RSUs Restricted stock units converted into common stock

RSU conversion price $0.0000 Conversion price for restricted stock units

Key Terms

Restricted Stock Unit, Omnibus Incentive Plan, Rule 16b-3

3 terms

Restricted Stock Unit financial

"The RSUs were granted on May 19, 2026, under the Issuer's 2024 & 2025 Omnibus Incentive Plan"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Omnibus Incentive Plan financial

"granted on May 19, 2026, pursuant to the Issuer's 2024 & 2025 Omnibus Incentive Plan"

An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.

Rule 16b-3 regulatory

"in a transaction exempt under Rule 16b-3"

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/11/2026 - 05:25 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bhutawala Suhel

(Last)

(First)

(Middle)

5 AG. GEORGIOU STR.

(Street)

PILEA

THESSALONIKI

TK57001

(City)

(State)

(Zip)

GREECE

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cosmos Health Inc. [ COSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $.001	05/19/2026	05/19/2026	A⁽¹⁾		20,000	A	$0.283	65,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽²⁾	05/19/2026	05/19/2026	C			20,000	05/19/2026	05/19/2036	Common Stock, par value $.001	20,000	$0	0	D

Explanation of Responses:

1. Reflects the award of 20,000 shares of Common Stock granted on May 19, 2026, pursuant to the Issuer's 2024 & 2025 Omnibus Incentive Plan, in a transaction exempt under Rule 16b-3.

2. The RSUs were granted on May 19, 2026, under the Issuer's 2024 & 2025 Omnibus Incentive Plan and vested on the date of the grant, in a transaction exempt under Rule 16b-3.

	/s/ Suhel Bhutawala	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Cosmos Health (COSM) director Suhel Bhutawala report on this Form 4?

Director Suhel Bhutawala reported receiving 20,000 shares of Cosmos Health common stock. The shares were granted as equity compensation and came from vested restricted stock units under the company’s 2024 & 2025 Omnibus Incentive Plan.

How many Cosmos Health shares did Suhel Bhutawala receive and at what value?

Suhel Bhutawala received 20,000 shares of Cosmos Health common stock valued at $0.283 per share. This reflects the equity grant recorded on the Form 4 as part of his director compensation package.

What happened to Suhel Bhutawala’s restricted stock units in Cosmos Health?

Bhutawala’s 20,000 restricted stock units vested and were converted into 20,000 shares of Cosmos Health common stock. The RSUs had a conversion price of $0.0000 and were issued under the 2024 & 2025 Omnibus Incentive Plan.

How many Cosmos Health shares does Suhel Bhutawala hold after this transaction?

After the equity award and RSU conversion, Suhel Bhutawala directly holds 65,000 shares of Cosmos Health common stock. This total holding is reported as the number of shares beneficially owned following the transaction.

Was Suhel Bhutawala’s Cosmos Health equity grant an open-market purchase?

No, the 20,000 shares were not bought on the open market. They were granted as compensation and issued through restricted stock units that vested immediately in a transaction exempt under Rule 16b-3.

Under which plan were Suhel Bhutawala’s Cosmos Health shares granted?

The 20,000 shares granted to Suhel Bhutawala came under Cosmos Health’s 2024 & 2025 Omnibus Incentive Plan. This plan governs equity-based compensation such as restricted stock units for directors and other participants.